High risk cardiac surgery in Jehovah's Witnesses

Journal of Cardiovascular Surgery

Volumn 37, Issue 5, 1996, Pages 511-515

  Grebenik, C R ^a   Sinclair, M E ^a   Westaby, S ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Christianity; Heart surgery

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; FEMALE; HEART SURGERY; HIGH RISK PATIENT; HUMAN; MALE; RELIGION;

ADULT; AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CHRISTIANITY; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; RELIGION AND MEDICINE; RISK FACTORS; VASCULAR SURGICAL PROCEDURES;

EID: 0029911326     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. The Watchtower, 1978, June 15: 30
2. Ott DA, Cooley DA. Cardiovascular surgery in Jehovah's Witnesses, JAMA 1977,238:1256-8.
3. Jones JA. Red blood cell substitutes: current status. Br J Anaesth 1995,74.697-703.
4. Goodnough LT, Johnston MFM, Toy PTCY The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991;265:86-90
5. Owings DV, Kruskall MS, Thurer RL, Donovan LM. Autologous blood donations prior to elective cardiac surgery Safety and effect on subsequent blood use. JAMA 1989,262:1963-8
6. Gaudiani VA, Mason DW. Preoperative erythropoietin in Jehovah's Witnesses who require cardiac procedures Ann Thorac Surg 1991;51 823-4
7. Neustein SM, Bronheim D, Galla J et al. The role of erythropoetin in Jehovah's Witnesses requiring cardiac surgery. J Cardiothorac Vasc Anesth 1993;7 95-102.
8. Levine EA, Rosen AL, Sehgal LR, Gould SA, Egrie JC, Moss GS Erythropoietin deficiency after coronary bypass procedures Ann Thorac Surg 1991,51:764-6.
9. Trouwborst A, Hagenouw RRPM, Jeekel J, Ong GL. Hypervolaemic haemodilution in an anaemic Jehovah's Witness Br J Anaesth 1990,64:646-8.
10. Messmer K. Hemodilution: possibilities and safety aspects. Acta Anaesthesiol Scand Suppl 1988;32:49-53.
11. The Watchtower 1989, March 1 30-1.
12. Fremes SE, Wong BI, Lee E et al Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding. Ann Thorac Surg 1994,58:1580-8.
13. Royston D, Bidstrup B, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987;ii:1289-91.
14. Hunt BJ, Yacoub M. Aprotinin and cardiac surgery, BMJ 1991,303 660-1.
15. Westaby S. Aprotinin in perspective Ann Thorac Surg 1993;55:1033-41.
16. Cosgrove DM, Heric B, Lytle BW et al. Aprotinin for reoperative myocardial revascularization: a placebo-controlled study Ann Thorac Surg 1992,54:1031-8
17. Hartz RS, Smith JA, Green D. Autotransfusion after cardiac operation J Thorac Cardiovasc Surg 1988,96.178-82.
18. Axford TC, Dearani JA, Ragno G et al Safety and therapeutic effectiveness of reinfused shed blood after open heart surgery. Ann Thorac Surg 1994,57:615-22
19. Schonberger JPAM, van Oeveren W, Bredee JJ, Everts PAM, de Haan J, Wildevuur CRH. Systemic blood activation during and after autotransfusion Ann Thorac Surg 1994,57.1256-62.
20. Cosgrove DM, Loop FD, Lytle BW. Determinants of blood utilization during myocardial revascularization. Ann Thorac Surg 1985;40 380-4.
21. Finfer S, Howell S, Miller J, Willett K, Wilson-MacDonald J. Major trauma in two patients refusing blood transfusion Br Med J 1994.308:1423-4.
22. Dake MD, Miller DC, Semba CP, Scott Mitchell R, Walker PJ, Liddel RP. Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aneurysms. N Engl J Med 1994,331:1729-34.
23. Harker LA Bleeding after cardiopulmonary bypass. N Engl J Med 1986,314(22):1446-7